This study revealed that IL-6, IL-1beta, and other inflammatory factors are highly expressed in samples from pancreatic cancer patients compared with the corresponding matching normal tissue, and this result is consistent with previous findings. This evidence concerns the gene IL1B and familial pancreatic carcinoma.